MktsMarkets

Pfizer, Inc.
NYSE: PFEKey statistics
PFE News
Stories mentioning PFE from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 29 | Q4 '25Dec 31 | Q3 '25Sep 28 | Q2 '25Jun 29 | Q1 '25Mar 30 | Q4 '24Dec 31 | Q3 '24Sep 29 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 14,451,000 | 17,557,000 | 16,654,000 | 14,653,000 | 13,715,000 | 17,763,000 | 17,702,000 | 13,283,000 |
| Cost of Goods Sold | 3,548,000 | 5,272,000 | 4,172,000 | 3,778,000 | 2,845,000 | 5,909,000 | 5,263,000 | 3,300,000 |
| Gross Profit | 10,903,000 | 12,285,000 | 12,482,000 | 10,875,000 | 10,870,000 | 11,854,000 | 12,439,000 | 9,983,000 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 2,961,000 | 4,162,000 | 3,186,000 | 3,415,000 | 3,031,000 | 4,274,000 | 3,244,000 | 3,717,000 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | ||||||||
| Interest Income | 115,000 | 166,000 | 138,000 | 156,000 | 143,000 | 170,000 | 116,000 | 130,000 |
| Interest Expense | 668,000 | 711,000 | 652,000 | 654,000 | 654,000 | 740,000 | 783,000 | 778,000 |
| Other Expense | (861,000) | (4,515,000) | (517,000) | (739,000) | (953,000) | (2,358,000) | (243,000) | (1,107,000) |
| Pretax Income | 3,170,000 | (1,643,000) | 3,334,000 | 3,044,000 | 2,785,000 | (10,000) | 4,715,000 | (103,000) |
| Tax Provision | 461,000 | (2,000) | (216,000) | 141,000 | (189,000) | (421,000) | 234,000 | (134,000) |
| Net Income (Loss) | 2,687,000 | (1,647,000) | 3,541,000 | 2,910,000 | 2,967,000 | 410,000 | 4,465,000 | 41,000 |
| Earnings Per Share (Basic) | 0.47 | (0.29) | 0.62 | 0.51 | 0.52 | 0.07 | 0.79 | 0.01 |
| Earnings Per Share (Diluted) | 0.47 | (0.29) | 0.62 | 0.51 | 0.52 | 0.07 | 0.78 | 0.01 |
| Weighted Average Shares Outstanding (Basic) | 5,691,000 | 5,683,000 | 5,685,000 | 5,685,000 | 5,675,000 | 5,664,000 | 5,667,000 | 5,666,000 |
| Weighted Average Shares Outstanding (Diluted) | 5,731,000 | 5,713,000 | 5,714,000 | 5,706,000 | 5,710,000 | 5,700,000 | 5,705,000 | 5,696,000 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About PFE
Pfizer, Inc. (NYSE: PFE) is a stock listed on the New York Stock Exchange under the ticker symbol PFE. It last traded at $28.06 (Nov 18, 2026, 9:30 AM ET), down 1.4% on the day. That gives Pfizer a market capitalisation of $163.0B and a price-to-earnings ratio of 40.4.
Over the past 52 weeks PFE has traded between $23.62 and $31.44.
Revenue for the quarter ended Mar 29, 2026 was $14.5B; net income $2.7B. Revenue was up 5.4% from $13.7B in the quarter ended Mar 30, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 29, 2026 | $14.5B | $2.7B | 18.6% |
| Dec 31, 2025 | $17.6B | -$1.6B | -9.4% |
| Sep 28, 2025 | $16.7B | $3.5B | 21.3% |
| Jun 29, 2025 | $14.7B | $2.9B | 19.9% |
From Pfizer’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…